Ledger.Open graph →
SEC Form D · filed February 22, 2013

Revance Therapeutics, Inc

Offering
$60.0M
Sold
$5.0M
Exemption
—
Industry
Pharmaceuticals
Location
NEWARK, CA
Type
—

People & firms on this filing (16)

Vicente Trelles · Newark, CADirectorPhyllis Gardner · Newark, CADirectorRonald Eastman · Newark, CADirectorL. D. Browne · Newark, CAExec · DirectorJonathan Tunnicliffe · Newark, CADirectorJim Glasheen · Newark, CADirectorRobert Byrnes · Newark, CADirectorFrank Kung · Newark, CADirectorJoel R. Beaudin · North River, NYExec · DirectorDan Beecroft · Boca Raton, FLDirectorBlake Beecroft · Boca Raton, FLDirectorToney Jennings · Austin, TXDirectorDaniel M. Teal · Austin, TXDirectorRichard Teal · Austin, TXDirectorJan Steenbrugge · Boston, MADirectorGeorge Bashforth · GRAND CAYMAN, Cayman IslandsDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗